Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1399 clinical trials
Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer

Additionally, the 8-12 week rest period from the end of the chemoradiotherapy and the radical surgery, treatment with durvalumab may continue improving the response and outcome of patients without jeopardizing the surgery (which needs this period out of chemotherapy and radiotherapy to avoid postoperative complications, but not for anti-PDL-1 therapy). …

vascular invasion
chemoradiotherapy
hormone levels
mfolfox-6
hepatitis c
  • 0 views
  • 19 Feb, 2024
  • 10 locations
Liaqun-Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting  

By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care.This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns …

  • 0 views
  • 27 Apr, 2026
  • 1 location
Doxapram Therapy in Preterm Infants (DOXA Trial)

Doxapram is a respiratory stimulant that has been administered off-label to treat AOP. Doxapram, as add-on treatment, seems to be effective in treating AOP and to prevent invasive mechanical ventilation. It is unclear if a preterm infant benefit from doxapram treatment on the longer term.

doxapram
nervous
continuous positive airway pressure
mechanical ventilation
off-label
  • 0 views
  • 19 Feb, 2024
  • 18 locations
Does Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis?

Operators will landmark for paracentesis using conventional physical exam and then utilize POCUS to determine if there is a more optimal site. The primary endpoint will be whether POCUS yielded a change in the needle insertion site, as defined by a location greater than 5cm from the anatomic site, at …

thoracentesis
paracentesis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Restrictive Use of Dexamethasone in Glioblastoma

The purpose of this study is to assess whether selected GBM patients can be treated safely with a restrictive DEX regimen from referral to the neurosurgical center until discharge. The primary objective is to determine the failure rate of a restrictive DEX regimen defined as edema or mass effect leading …

immunosuppression
dexamethasone
glioblastoma multiforme
neurologic symptoms
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

This randomized phase II study will evaluate the efficacy of nivolumab plus paclitaxel for first-line treatment of recurrent or metastatic HNSCC in the platinum ineligible and platinum refractory settings. Control arm will be paclitaxel in combination with cetuximab, treatment included in the guidelines of the Spanish Society of Medical Oncology.

tumor of the oropharynx
liver metastasis
heart disease
measurable disease
leptomeningeal metastases
  • 0 views
  • 19 Feb, 2024
  • 20 locations
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

Early use of rituximab was associated with better clinical outcomes, hence combination treatment of rituximab and intravenous immunoglobulins (IVIG) has shown to be effective for refractory pemphigus cases and can potentially induce long-term complete remission and lower risks infectious complications.

tositumomab
immunoglobulin g
remission
prednisolone
indirect immunofluorescence
  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant mFOLFOXIRI Plus Bevacizumab With Selective Radiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer

On the basis of the results of these trials, The investigators hypothesized that radiotherapy could be selectively omitted for patients who respond to NACT alone. The results of TRIBE showed that FOLFOXIRI plus bevacizumab yield a high objective response rate (ORR) (65%), early tumor shrinkage (ETS) (62.7%) and depth of …

rectal cancer
mri pelvis
chemoradiotherapy
mfolfox-6
total mesorectal excision
  • 0 views
  • 19 Feb, 2024
  • 1 location
Optimized Tailored Interventions in Metabolic and Lifestyle Outcomes (OPTIMAL)

Our research team will evaluate three different groups: the first group will be chosen using a predictive analytics model that predicts who will benefit most from the MIND diet, the second group will follow the MIND diet without being pre-selected, and the third group will eat a standard healthy diet …

Accepts healthy volunteers
  • 0 views
  • 19 May, 2025
  • 1 location
Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia  

Post herpetic neuralgia (PHN) represents a potentially debilitating and often undertreated form of neuropathic pain that disproportionately affects vulnerable populations, including the elderly and the immunocompromised. PHN pain is typically localized, unilateral and chronic, but may be constant, intermittent, spontaneous and/or evoked. PHN is likely to interfere with sleep and …

  • 0 views
  • 03 Dec, 2025
  • 1 location